Literature DB >> 383128

Lactoperoxidase activity in guinea-pig milk and saliva: correlation in milk of lactoperoxidase with bactericidal activity against Escherichia coli.

S Stephens, R A Harkness, S M Cockle.   

Abstract

The lactoperoxidase (LPO) activity in guinea-pig milk and saliva has been investigated in sows suckling normal young, and young orally infected with Escherichia coli. There was a 5-fold increase in activity in milk during the 3--4 weeks of lactation; infection of the young did not alter this. There was no comparable increase in lactoperoxidase activity of saliva during this same period, either in the infected or non-infected group. The antibacterial activity of milk from sows suckling normal young increased with the lactoperoxidase, and this bactericidal activity could be reversed by LPO inhibitors such as penicillamine and cysteine but not by addition of sufficient iron to saturate the lactoferrin. In milk from sows suckling infected young, bacteriostatic activity occurring in samples from about 14 days after infection needed iron or both iron and penicillamine (or cysteine) for reversal, indicating that both the antibody-lactoferrin system and the LPO system may be involved in the infected state.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 383128      PMCID: PMC2041459     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  20 in total

1.  THE ANTILACTOBACILLUS SYSTEM OF SALIVA. ROLE OF SALIVARY PEROXIDASE.

Authors:  S J KLEBANOFF; R G LUEBKE
Journal:  Proc Soc Exp Biol Med       Date:  1965-02

2.  Lactoperoxidase activity in human milk and in saliva of newborn infants.

Authors:  L Gothefors; S Marklund
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Peroxidase from human cervical mucus. The isolation and characterisation.

Authors:  J S Shindler; R E Childs; W G Bardsley
Journal:  Eur J Biochem       Date:  1976-06-01

5.  Nonspecific bactericidal activity of the lactoperoxidases-thiocyanate-hydrogen peroxide system of milk against Escherichia coli and some gram-negative pathogens.

Authors:  B Reiter; V M Marshall; C G Rosén
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

6.  Stimulation of the development of bacteriostatic activity of guinea-pig milk against Escherichia coli.

Authors:  S Stephens; J M Dolby
Journal:  Br J Exp Pathol       Date:  1978-04

7.  Susceptibility of Escherichia coli to bactericidal action of lactoperoxidase, peroxide, and iodide or thiocyanate.

Authors:  E L Thomas; T M Aune
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

8.  Antibacterial activity of the lactoperoxidase system in milk against pseudomonads and other gram-negative bacteria.

Authors:  L Björck; C Rosén; V Marshall; B Reiter
Journal:  Appl Microbiol       Date:  1975-08

9.  Changes in salivary peroxidase and polymorphonuclear neutrophil leucocyte enzyme activities during the menstrual cycle.

Authors:  S M Cockle; R A Harkness
Journal:  Br J Obstet Gynaecol       Date:  1978-10

10.  Progesterone-binding globulin and testosterone-binding activity in guinea pig serum during pregnancy: relationship to progesterone and oestrogens.

Authors:  O A Lea; A Bessesen; K F Stoa
Journal:  Acta Endocrinol (Copenh)       Date:  1976-02
View more
  3 in total

Review 1.  Antimicrobial actions of dual oxidases and lactoperoxidase.

Authors:  Demba Sarr; Eszter Tóth; Aaron Gingerich; Balázs Rada
Journal:  J Microbiol       Date:  2018-06-01       Impact factor: 3.422

2.  The effect of freezing and pasteurizing bovine milk on its ability to protect neonatal guinea-pigs against colonization of the small intestine by Escherichia coli.

Authors:  J M Dolby; S Stephens; J P Royston
Journal:  Br J Exp Pathol       Date:  1980-02

3.  Oestrogens and host resistance.

Authors:  R A Harkness
Journal:  J R Soc Med       Date:  1980-03       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.